C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.
C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber Disease.
复制标题
DOI:
10.1038/s41598-017-06604-2
复制
发表时间:
2017-07-21
影响因子:
4.6
通讯作者:
Rolfs A
中科院分区:
文献类型:
--
作者:
Cozma C;Iurașcu MI;Eichler S;Hovakimyan M;Brandau O;Zielke S;Böttcher T;Giese AK;Lukas J;Rolfs A
Farber disease (FD) is a rare autosomal recessive disease caused by mutations in the acid ceramidase gene (ASAH1). Low ceramidase activity results in the accumulation of fatty substances, mainly ceramides. Hallmark symptoms at clinical level are periarticular nodules, lipogranulomas, swollen and painful joints and a hoarse voice. FD phenotypes are heterogeneous varying from mild to very severe cases, with the patients not surviving past their first year of life. The diagnostic aspects of FD are poorly developed due to the rarity of the disease. In the present study, the screening for ceramides and related molecules was performed in Farber affected patients (n = 10), carriers (n = 11) and control individuals (n = 192). This study has the highest number of enrolled Farber patients and carriers reported to present. Liquid chromatography multiple reaction mass spectrometry (LC/MRM-MS) studies revealed that the ceramide C26:0 and especially its isoform 1 is a highly sensitive and specific biomarker for FD (p < 0.0001). The new biomarker can be determined directly in the dried blood spot extracts with low sample consumption. This allows for easy sample preparation, high reproducibility and use in high throughput screenings.
登录
查看更多内容
DOI:
10.1007/8904_2013_246
发表时间:
2014-01-01
期刊:
JIMD REPORTS, VOL 12
影响因子:
--
作者:
Ferreira, Natalia Santos;Goldschmidt-Arzi, Michal;Futerman, Anthony H.
通讯作者:
Futerman, Anthony H.
影响因子:
9.3
作者:
De Jesus, Victor R.;Zhang, X. Kate;Hannon, W. Harry
通讯作者:
Hannon, W. Harry
影响因子:
11.1
作者:
Alayoubi, Abdulfatah M.;Wang, James C. M.;Medin, Jeffrey A.
通讯作者:
Medin, Jeffrey A.
影响因子:
3.9
作者:
Bär, J;Linke, T;Sandhoff, K
通讯作者:
Sandhoff, K
影响因子:
3.5
作者:
Hammad SM;Baker NL;El Abiad JM;Spassieva SD;Pierce JS;Rembiesa B;Bielawski J;Lopes-Virella MF;Klein RL;DCCT/EDIC Group of Investigators
通讯作者:
DCCT/EDIC Group of Investigators